Translational Breast Cancer Research (Transl Breast Cancer Res, TBCR) launched in November 2019, is an open access, peer-reviewed journal focusing on translational research in breast cancer.
As a quarterly published journal, the journal seeks to create a platform for researchers and clinicians by presenting pertinent investigations, for discussing critical questions relevant to the entire fields of breast cancer, and aiming to develop new perspectives for all those issues concerned with breast cancer.
As one of the most serious problems of oncology and the leading cause of death of women in many countries, breast cancer is truly a multidisciplinary problem to be handled. Each issue will contain articles dealing with laboratory investigations as well as articles dealing with clinical studies.
The journal features original articles, cutting-edge reviews, case reports and some short but thought-provoking articles like editorial commentaries, thus representing a source of valuable, novel information for clinical and basic researchers alike. The entire submission and review process are managed through OJS, an electronic system to increase efficiency and ensure that submissions can be published within a short turnaround period.
Submission Turnaround Time:
- In-house review: 3-5 days
- External peer review: 2-3 months
- Revision time: 2-4 weeks
- Publication Ahead of Print: within 1 month upon acceptance
- Formal publication: within 1-3 months after being accepted. Original Articles and Clinical Guidelines are listed as priority.
AME Publishing Company
Address: Rm C, 16/F, Kings Wing Plaza 1, No. 3 On Kwan Street, Shatin, NT, Hong Kong
Phone: +86 20 66355775